MedPath

Clinical Data Collection in Breast Tomosynthesis (COBRIS)

Not Applicable
Recruiting
Conditions
Breast Cancer
Interventions
Device: Breast Tomosynthesis
Registration Number
NCT05914168
Lead Sponsor
GE Healthcare
Brief Summary

The purpose of the study is to assess an image acquisition application for breast tomosynthesis in a clinical environment

Detailed Description

After being informed about the study and potential risks, all patients giving written informed consent will undergo their routine mammography examination. One additional mammography view will be obtained with the investigational application and analyzed. Subject participation is expected to last no more than 30 minutes. After the mammography examination, subjects will be followed according to the hospital standard of care.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • Women aged 35 years or older;
  • Women referred for unilateral or bilateral 2D and 3D mammography;
  • Women able and willing to comply with study procedures;
  • Women able and willing to participate in this study who have signed and dated the informed consent form; and
  • Women surgically sterile or postmenopausal or, the possibility of pregnancy is ruled out based on a negative urine pregnancy test
Exclusion Criteria
  • Women who have been previously included in this study; or
  • Be a minor, protected adult, adult deprived of liberty by judicial or administrative decision, pregnant, parturient or a breastfeeding mother; or
  • Women with BRCA 1 or BRCA 2 gene mutation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Study armBreast TomosynthesisSubjects with investigational acquisition
Primary Outcome Measures
NameTimeMethod
Data Collection1 year

Collect clinical breast images obtained with the investigational application.

Secondary Outcome Measures
NameTimeMethod
Assessment of Image Quality1 year

Assess image quality through subjective and open expert evaluation of patient motion, visibility of replication artefacts and visibility of clinical findings.

Trial Locations

Locations (1)

Gustave Roussy

🇫🇷

Villejuif, France

© Copyright 2025. All Rights Reserved by MedPath